Fournier, C. (2023). Tebentafusp: A New Systemic Treatment for Unresectable or Metastatic Uveal Melanoma in HLA-A*02:01-positive patients. Canadian Dermatology Today, 4(3), 5–10. Retrieved from https://canadiandermatologytoday.com/article/view/4-3-fournier